mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |